Log in to save to my catalogue

Single-dose azithromycin for infant growth in Burkina Faso: Prespecified secondary anthropometric ou...

Single-dose azithromycin for infant growth in Burkina Faso: Prespecified secondary anthropometric ou...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_3069183085

Single-dose azithromycin for infant growth in Burkina Faso: Prespecified secondary anthropometric outcomes from a randomized controlled trial

About this item

Full title

Single-dose azithromycin for infant growth in Burkina Faso: Prespecified secondary anthropometric outcomes from a randomized controlled trial

Publisher

United States: Public Library of Science

Journal title

PLoS medicine, 2024-01, Vol.21 (1), p.e1004345-e1004345

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Antibiotic use during early infancy has been linked to childhood obesity in high-income countries. We evaluated whether a single oral dose of azithromycin administered during infant-well visits led to changes in infant growth outcomes at 6 months of age in a setting with a high prevalence of undernutrition in rural Burkina Faso.
Infants were enr...

Alternative Titles

Full title

Single-dose azithromycin for infant growth in Burkina Faso: Prespecified secondary anthropometric outcomes from a randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_3069183085

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_3069183085

Other Identifiers

ISSN

1549-1676,1549-1277

E-ISSN

1549-1676

DOI

10.1371/journal.pmed.1004345

How to access this item